You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 120 No. 5, May 1985 TABLE OF CONTENTS
  Archives
  •  Online Features
  PAPERS READ BEFORE THE 92ND ANNUAL MEETING OF THE WESTERN SURGICAL ASSOCIATION, COLORADO SPRINGS, COLO, NOV 12-14, 1984-PART I
 This Article
 •References
 •Full text PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Citing articles on Web of Science (27)
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Management of Hypercalcemic Hyperparathyroidism After Renal Transplantation

Paul J. Garvin, MD; Marco Castaneda, MD; Rob Linderer, RN; Maureen Dickhans, BSN, MS

Arch Surg. 1985;120(5):578-583.


Abstract

• To determine the optimal management of posttransplant hypercalcemia, a chart analysis of 100 stable renal allograft recipients (longer than one year) was accomplished. The incidence of hypercalcemia ranged from 12% to 20% up to 30 months after transplantation. The mean serum alkaline phosphatase level, phosphate level, and duration of dialysis in hypercalcemic patients did not differ significantly from normocalcemic patients; however, serum creatinine levels were significantly lower at 12 and 24 months in patients with hypercalcemia. In patients with hypercalcemia at three and six months, greater than 50% underwent spontaneous resolution, whereas this occurred in 25% of the patients with hypercalcemia at 12 months. Seven patients underwent parathyroidectomy with prompt resolution of their hypercalcemia and ten patients with persistent hypercalcemia have been followed up from 14 to 66 months without sequelae of hyperparathyroidism. In conclusion, hypercalcemic hyperparathyroidism is a frequent occurrence after renal transplantation. Sequelae of this condition are rare, however, and parathyroidectomy should be reserved for progressive clinical and/or roentgenographic findings.

(Arch Surg 1985;120:578-583)



Author Affiliations

From the Department of Surgery, St Louis University School of Medicine (Dr Garvin and Mr Linderer and Ms Dickhans); and the Transplant Unit, John Cochran Veterans Administration Medical Center, St Louis (Drs Garvin and Castaneda).


Footnotes

Accepted for publication Nov 19, 1984.

Read before the 92nd annual meeting of the Western Surgical Association, Colorado Springs, Colo, Nov 13, 1984.

Reprint requests to the Department of Surgery, St Louis University Hospitals, 1325 S Grand Blvd, St Louis, MO 63104 (Dr Garvin).



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Decreased renal transplant function after parathyroidectomy
Schwarz et al.
Nephrol Dial Transplant 2007;22:584-591.
ABSTRACT | FULL TEXT  

Tertiary Hyperparathyroidism: Histologic Patterns of Disease and Results of Parathyroidectomy
Kebebew et al.
Arch Surg 2004;139:974-977.
ABSTRACT | FULL TEXT  

Recommendations for the Outpatient Surveillance of Renal Transplant Recipients
KASISKE et al.
J. Am. Soc. Nephrol. 2000;11 :S1-S86.
ABSTRACT | FULL TEXT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1985 American Medical Association. All Rights Reserved.